Intec Pharma Ltd (NASDAQ:NTEC) shares shot up 2.6% on Thursday . The company traded as high as $6.27 and last traded at $6.20, with a volume of 51,681 shares changing hands. The stock had previously closed at $6.04.

Separately, Zacks Investment Research upgraded shares of Intec Pharma from a “sell” rating to a “hold” rating in a research note on Friday, May 27th.

The stock’s market capitalization is $70.63 million. The company’s 50-day moving average price is $5.52 and its 200-day moving average price is $4.43.

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.